Loading...

SILO SILO PHARMA INC Contract Awards 8-K Filing

SL P

SL

SILO PHARMA INC

(SILO)

2025 8-K

Show Summary

Show Summary

Equity Offerings

Investor Presentation

Shareholder Update

Annual Meeting Results

Annual Meeting Postponed

Investor Presentation

Securities Purchase Agreement

License Agreement with Colu...

Agreement Amendment

Securities Purchase Agreement

Other Special Situation

Stock Repurchase Program Ex...

Pipeline Prioritization Ann...

Amendment to Stock Repurcha...

Stock Repurchase Program Ex...

Change of Incorporation State

Annual Meeting Approval

Stock Authorization Decrease

Annual Meeting of Stockholders

Patent Application

Extension of License Agreement

Patent Application

Patent Application Filing

Patent Issuance

Stock Repurchase Program

Patent Applications

External Links:

Silo Pharma, Inc. shared a letter to shareholders discussing the progress and potential of its lead assets SPC-15 and SP-26 for treating mental health and chronic pain, while cautioning that forward-looking statements are subject to risks and uncerta

AI Assistant

SILO PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.